D-0560-2022 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- February 23, 2022
- Initiation Date
- January 14, 2022
- Termination Date
- July 31, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 115776 bottles
Product Description
Moxifloxacin Ophthalmic Solution, USP 0.5% w/v, 3 mL bottle, Sterile, Rx Only, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ 08520, Made in India, NDC 65862-840-03
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution Pattern
USA Nationwide
Code Information
Lot#: CMF210001, CMF210003, CMF210004, Exp 6/2023